NYSE · GRDN

Guardian Pharmacy Services, Inc.

$40.45 +$1.01 (+2.56%) 1D Market open

Key Metrics

$2.56B
Market cap
48.27×
P/E · TTM
$1.46B
Revenue · TTM
$53.07M
Net income
EPS · TTM $0.84
Dividend yield
Free cash flow
Beta · 1Y 0.73
EBITDA · TTM $101.65M
Gross margin 20.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    Money has been moving out of its sector (Consumer Discretionary).

    Consumer Discretionary has run -5.7 points vs SPY over four weeks, ranking 3→5→10→11 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    The stock moved +8.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 26
  • Mar 30
    The stock moved +9.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.56B
Enterprise value
Shares outstanding63.3M
52-wk range$19.30 – $44.00
Avg volume · 20D279.4K
Net cash
Book value / share$3.67
IndustryRetail-Drug Stores And Proprietary Stores
ExchangeNYSE
About Guardian Pharmacy Services, Inc.
IPO dateSep 26, 2024
Employees3600

Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E48.27
P/S1.76
P/FCF
EV/EBITDA
EV/Sales
Graham №$8.32

Profitability

Gross 20.9%
Operating 5.4%
Net 3.6%
FCF
ROE / ROIC 22.8% · 31.8%

Financial Health

Current ratio1.46
Quick ratio1.17
Debt / equity
Debt / EBITDA
Net cash
Working capital$74.64M

Cash Flow · TTM

Operating CF $88.77M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

12.4
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$8.32 vs $40.45
Trades 4.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings